Ye et al. found that propofol could upregulate miR-1-3p in CRC cells, thereby inhibiting the activation of IGF1 and the AKT/mTOR axis, which was able to inhibit cell proliferation and promote apoptosis. Here, IGF1 is linked to colorectal carcinoma.